
浏览全部资源
扫码关注微信
纸质出版日期:2015
移动端阅览
张明丽, 姜瑞雪. 益气活血汤对慢性心力衰竭气虚血瘀证患者心功能及生活质量的影响[J]. 中国实验方剂学杂志, 2015,21(19):162-166.
ZHANG Ming-li, JIANG Rui-xue. Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 162-166.
张明丽, 姜瑞雪. 益气活血汤对慢性心力衰竭气虚血瘀证患者心功能及生活质量的影响[J]. 中国实验方剂学杂志, 2015,21(19):162-166. DOI: 10.13422/j.cnki.syfjx.2015190162.
ZHANG Ming-li, JIANG Rui-xue. Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 162-166. DOI: 10.13422/j.cnki.syfjx.2015190162.
目的:观察益气活血汤对气虚血瘀证慢性心力衰竭(CHF)患者心功能和生活质量的疗效
对血清胱抑素 C(Cys C)
同型半胱氨酸(Hcy)和亲环素(CypA)的影响。方法:将118例CHF(气虚血瘀证)采用随机按数字表法分为对照组和治疗组各59例。对照组口服双氢克尿噻片
25 mg/次
1次/d;口服卡托普利片
12.5 mg
2次/d;地高辛片
0.25 mg
1次/d; 口服倍他乐克
25 mg
2次/d。观察组在对照组的基础上加用益气活血内服
1剂/d
分2次服用。两组均连续治疗4周。对两组患者治疗前后的Lee氏评分、美国纽约心脏病协会(NYHA)心功能分级评价
6 min步行实验(6 MWT)和临床症状积分进行比较;采用明尼苏达心衰生活质量调查表评价两组患者生活质量;采用彩色超声多普勒诊断系统测定两组患者左心室射血分数(LVEF)和舒张早期/舒张晚期最大血流速度(E/A)值;检测两组患者Cys C
Hcy和Cyp A水平。结果:观察组临床总有效率为93.22%
对照组为79.66%
观察组优于对照组(P<0.05);治疗后观察组6 MWT多于对照组
生活质量、中医证候积分低于对照组(P<0.05);两组患者治疗后LVEF和E/A均明显增高(P<0.01)
观察组LVEF和E/A比对照组增高更为显著(P<0.05);治疗后观察组Cys C
Hcy和Cyp A水平均低于对照组(P<0.05)。结论:在常规强心、利尿的基础上
益气活血汤可改善气虚血瘀型CHF患者的心功能、提高生活质量
其作用可能与降低Cys C
Hcy和Cyp A水平有关。
Objective: To observe the therapeutic efficacy of Yiqi Huoxue decoction on cardiac function and life quality in patients with qi-deficiency and blood stasis syndrome in chronic heart failure (CHF)
as well as its impact on cystatin C (Cys C)
homocysteine(Hcy)
and cyclophilin A(Cyp A) in serum. Method: One hundred and eighteen patients with CHF (Qi deficiency and blood stasis syndrome) were randomly assigned to either control group or observation group of 59 patients each according to random number table. Two groups were treated according to the guide of the diagnosis and treatment of chronic heart and failure. Patients of control group accepted hydrochlorothiazide tablet (25 mg/time
qd)
captopril (12.5 mg and bid)
digoxin tablet (0.25 mg and qd)
and Metoprolol(25 mg
bid).The patients of observation group were treated with additional Yiqi Huoxue decoction based on control treatment
1 dose/d and bid. Treatment course was 4 weeks in both groups. Lee's CHF score
NYHA cardiac heart grading
6 minutes walk test (6 MWT)
and clinical symptom score were compared between both groups before and after treatment. The quality of life of the two groups was evaluated by the minnesota heart failure life quality questionnaire. Left ventricular ejection fraction (LVEF) and E/A were detected using color Doppler ultrasound diagnostic system.Cys C
Hcy and Cyp A were tested in both groups. Result: Total effective rate for observation group was 93.22%
higher than 79.66% in control group (P<0.05). After treatment
6 MWT in observation group was higher than that of control group
while scores of life quality and Chinese medicine(TCM) syndrome were obviously lower than those of control group
with significant differences between two groups (P<0.05). After treatment
LVEF and E/A were obviously increased in both group (P<0.01)
and the increase value in observation group was higher than that in control group (P<0.05). After treatment
Cys C
Hcy
and Cyp A in observation group was remarkably lower than those in control group (P<0.05). Conclusion: Additional Yiqi Huoxue decoction based on the cardiotonic and diuretic therapy can improve cardiac function and life quality for CHF patients with heart qi deficiency and blood stasis
and its mechanism may be related to depressing Cys C
Hcy
and Cyp A levels.
0
浏览量
4
下载量
6
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621